Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif., January 4, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...
Events, News, Presentations, Press Releases
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer – Conference call and webcast to be held on Monday, January 9, 2023 at 1:30 pm PT, or 4:30 pm ET – SOUTH SAN FRANCISCO, Calif., December...
Events, News, Presentations
64th American Society of Hematology Annual Meeting and Exposition – Non-Audio Presentation...
Events, News, Presentations, Press Releases
Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022 – A total of 17 pediatric patients were treated with STRO-002 on a compassionate use basis; eight...
Events, News, Presentations, Press Releases
Sutro Biopharma to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., November 23, 2022 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...